Personalized treatment selection for advanced cancer patients
Part of Cancer clinical trials.
This study uses your tumor's genetic information to help your doctor choose the best standard treatment for your type of cancer. By analyzing your tumor and blood samples, the study aims to personalize your cancer therapy and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a confirmed diagnosis of advanced or metastatic cancer (cancer that has spread).
- You are able to provide a tumor tissue sample or blood sample for genetic testing, or you already have genetic (DNA/RNA) test results.
- You are willing to follow the study plan and complete all required visits and tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether FDA-approved targeted drugs can help people with advanced cancer whose tumors have specific gene changes. It aims to match your tumor's unique genetic profile to a drug that may work better for you.
This trial studies whether giving a targeted cancer medicine based on tumor genetic/protein test results can help people with advanced, incurable cancers live longer. You may be eligible if your cancer has a “potentially actionable” change on testing and you meet health and follow-up requirements.
This trial uses genetic testing of your tumor to match you with a targeted therapy. It is for people with advanced solid tumors who have exhausted or cannot tolerate standard treatments.
This study tests targeted drugs or immunotherapy based on the genetic features of your tumor. It may help people with rare, advanced cancers whose disease has progressed after standard treatment options.
This early-phase study tests whether a personalized cancer treatment plan based on your tumor’s test results can help people with aggressive cancers that are hard to treat. It may be an option if standard treatments didn’t work, aren’t possible for you, or you have few treatment choices.
This study tests whether choosing cancer treatments based on the unique genetic changes in your tumor can help people with advanced cancer live longer. You would receive FDA-approved drugs that match your tumor's specific markers.
Hear when a new Advanced Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.